Jan 8, 2025

2024 in Review: A look back at the top stories of last year

From the passage of Canada’s National Strategy for Eye Care Act, to the world’s first eye transplant, to the approval of an FBC-funded clinical trial for a first-of-its-kind stem cell treatment, there’s was a lot to be excited about in 2024! If you’ve missed them, or need a refresher, we’ve gathered the top stories of the 2024 here for you.

In this special View Point we take a look back at the year.

We’ve also gathered the top 10 stories of the year for you:

1. Canada’s Vision Health Stakeholders Applaud Parliament’s Passage of Bill C-284, the National Strategy for Eye Care Act
2. Hype or Hope? Elon Musk’s Neuralink Device gets FDA Approval
3. Announcing the 2024 Clinician Scientist Emerging Leader Awards!
4. First Patients Treated in XLRP Gene Therapy Trial
5. Stem Cell Therapy Gets FDA Approval for Clinical Trials
6. Clinical Trial Results for New Treatments for AMD and DME
7. FBC Announces 2024 Research Grant Awardees, Providing Critical Seed Funding to Promising Early Career Researchers
8. Where Are They Now: Mike Sapieha — Bringing Innovation from the Bench to the Bedside for Aging Eye Diseases
9. Partnering with CIHR to Support the Future of Vision Research
10. World’s First Eye Transplant Completed

Help ensure 2025 has as much of an impact as 2024—make a donation today to help fund critical sight-saving research and provide education and connection programs for people living with vision loss.